Zai Lab ZLAB
NASDAQ ZLAB
$24.34 +2.30 (+10.44%)
As of: Oct 23, 2026 · 2:27 PM EDT

Zai Lab (ZLAB) Amortization of Deferred Charges (2024 - 2025)

Updated

Analysis

Zai Lab (ZLAB) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,128.99 Bn 1,097.58 Bn 19.71 Bn
2 Johnson & Johnson 634.51 Bn 554.37 Bn 17.30 Bn
3 AbbVie 505.90 Bn 479.01 Bn 12.70 Bn
4 Merck 357.53 Bn 311.91 Bn 12.21 Bn
5 Novartis Ag 289.94 Bn 253.93 Bn 11.24 Bn
6 Astrazeneca 265.41 Bn 239.09 Bn 12.86 Bn
7 Amgen 238.14 Bn 193.54 Bn 7.24 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Zai Lab 2.72 Bn 29.80 Mn 58.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 90,000.00
Jun 30, 2025 104,000.00
Mar 31, 2024 700,000.00
API Access

Zai Lab Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ZLAB&period=max&api_key=YOUR_API_KEY